相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis
Michal Ciurzynski et al.
CLINICAL RHEUMATOLOGY (2014)
Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study
Maurizio Turiel et al.
ARTHRITIS CARE & RESEARCH (2013)
L-Arginine in pregnant scleroderma patients
Dilia Giuggioli et al.
CLINICAL RHEUMATOLOGY (2010)
Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis
Theodoros Dimitroulas et al.
CLINICAL RHEUMATOLOGY (2010)
Early Detection of Cardiac Involvement in Systemic Sclerosis Assessed by Tissue-Doppler Echocardiography: Relationship with Neurohormonal Activation and Endothelial Dysfunction
Theodoros Dimitroulas et al.
JOURNAL OF RHEUMATOLOGY (2010)
Correlation of Biomarkers of Endothelium Dysfunction and Matrix Remodeling in Patients with Systemic Sclerosis
Sophie Blaise et al.
JOURNAL OF RHEUMATOLOGY (2009)
Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension
T. Dimitroulas et al.
RHEUMATOLOGY (2008)
Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin
J. Wipff et al.
RHEUMATOLOGY (2008)
Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine
A. Dooley et al.
RHEUMATOLOGY (2006)
Cardiovascular biology of the asymmetric dimethylarginine: Dimethylarginine dimethylaminohydrolase pathway
P Vallance et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Nitric oxide function in the skin
MM Cals-Grierson et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2004)
Asymmetric dimethylarginine (ADMA):: a key regulator of nitric oxide synthase
RH Böger et al.
ATHEROSCLEROSIS SUPPLEMENTS (2003)
Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon - Implications for vascular dysfunction and progression of disease
S Rajagopalan et al.
ARTHRITIS AND RHEUMATISM (2003)
Serum nitric oxide (NO) levels in systemic sclerosis patients: correlation between NO levels and clinical features
K Takagi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2003)
Nitric oxide and cell signaling; modulation of redox tone and protein modification
A Landar et al.
AMINO ACIDS (2003)
S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity:: Further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase
J Leiper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Differential expression of nitric oxide by dermal microvascular endothelial cells from patients with scleroderma
LI Romero et al.
VASCULAR MEDICINE (2000)
Mechanisms of the pro- and anti-oxidant actions of nitric oxide in atherosclerosis
RP Patel et al.
CARDIOVASCULAR RESEARCH (2000)